Pharmacy
The retail juggernaut has been meeting with hospital execs to brainstorm potential models for broadening its B2B supply arm, into supplying hospitals, systems.
A more transparent formulary design enables pharma companies of all sizes to be listed on the exchange, giving consumers more choice and leading to lower out-of-pocket expense, the company says.
Insurers are asked to submit by Feb. 21 written responses to questions such as treatment coverage for Medicare beneficiaries.
The increase represents a substantial impact, especially given the use of many high-cost drugs, the report says. The firm also points to biosimilars as opportunity to thwart spending.
Advisors to the ambitious plan include former CMS head Don Berwick, MD, and Harvard professor Clayton Christensen, among others.
The former Eli Lilly CEO also told the Senate Finance Committee affordability and the opioid epidemic round out his top four priorities.
Opioids and heroin play a big role, but so do variations in primary care and mental health services.
Attorneys general in Washington, Minnesota and New Mexico issued civil investigative demands about potentially anti-competitive business dealings.
Third-quarter revenue for the global pharma giant was drastically reduced in part by the temporary production shutdown, higher demand than planned and lost sales in certain markets due to the virus.
Amazon's potential foray into pharmacy business could squeeze providers' bottom lines even more.